Supplies of Shingrix have not kept pace with demand, and the vaccine’s maker, GlaxoSmithKline, expects shipping delays and order limits to continue through 2018.
While the older shingles vaccine, Zotavax, is not in short supply, Shingrix provides up to 90 percent greater protection and last longer, so providers prefer it for their patients.
The new vaccine was approved last fall by the FDA and is recommended by the CDC.
More articles on supply chain:
Jaundice meter recalled after serious newborn injuries: 4 things to know
FDA releases 2nd draft of its software pre-certification program
FDA approves 1st glucose monitoring system with implantable sensor, monitoring app
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
